Australia’s first COVID-19 treatment approved

The TGA has approved remdesivir for treatment of severe coronavirus infections The Therapeutic Goods Administration (TGA) has granted provisional approval to remdesivir (Veklury) as the first treatment option for COVID-19 in Australia, for use in adults and adolescent patients with severe symptoms who have been hospitalised. Australia is the one of the first regulators to

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Is the future looking more certain?
Next NAPSA welcomes new executive